Balyasny Asset Management LLC Insulet Corp Call Options Transaction History

Balyasny Asset Management LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$180.69 - $239.01 $2.44 Million - $3.23 Million	13,500 Added 270.0%	18,500 $4.31 Million
Q2 2024 Aug 14, 2024	BUY	$161.02 - $206.98 $805,100 - $1.03 Million	5,000 New	5,000 $1.01 Million
Q3 2023 Nov 14, 2023	BUY	$154.67 - $290.89 $9.81 Million - $18.4 Million	63,400 New	63,400 $10.1 Million

685

62.7M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.